Godavari Drugs Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Godavari Drugs Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
52W Low on Jun 01, 2023
-7.6
TTM PE Ratio
Below industry Median
16.6
Price to Book Ratio
Below industry Median
2.1
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is much higher than 1
1.2
RSI
RSI is mid-range
35
MFI
MFI is mid-range
33.2

Godavari Drugs Ltd shareholding Pattern

Promoter
53.2%
Public
46.3%
Promoter
53.2%
Public
46.4%
Promoter
53.2%
Public
46.3%
Promoter
53.2%
Public
46.3%
Promoter
53.1%
Public
46.4%
Promoter
53.1%
Public
46.4%

Godavari Drugs Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
95.20
10Day EMA
96.00
12Day EMA
96.20
20Day EMA
96.90
26Day EMA
97.20
50Day EMA
97.80
100Day EMA
98.00
200Day EMA
96.10
5Day SMA
96.00
10Day SMA
96.10
20Day SMA
97.50
30Day SMA
98.00
50Day SMA
97.50
100Day SMA
99.40
150Day SMA
97.40
200Day SMA
97.90
Delivery & Volume
Resistance & Support
93.10
Pivot
Resistance
First Resistance
94.25
Second Resistance
95.25
Third Resistance
96.40
Support
First Support
92.10
Second support
90.95
Third Support
89.95
Relative Strength Index
35.01
Money Flow Index
33.17
MACD
-0.97
MACD Signal
-0.64
Average True Range
3.98
Average Directional Index
13.93
Rate of Change (21)
-7.20
Rate of Change (125)
-5.76
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Makers Laboratories Ltd.
-
-
-
Godavari Drugs Ltd.
-
-
-
Vasundhara Rasayans Ltd.
-
-
-
ANG Lifesciences India Ltd.
-
-
-
Achyut Healthcare Ltd.
-
-
-
Shelter Pharma Ltd.
-
-
-
Mono Pharmacare Ltd.
-
-
-

Godavari Drugs Ltd Company background

Founded in: 1987
Managing director: Mukund Kakani
Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India.. Sulphamethoxazole (SMX), the main product of the company, is a widely used antibacterial drug enjoying good export demand. The Company incorporated in December, 1987, has multiple production blocks for APIs, drug intermediates and fine chemicals. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa).The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections. The backward integration into SMO and DEO will enhance valueaddition. In fact, Siris and Chemox Chemicals, both having good capacities of SMX, have recently gone in for the production of SMO. In 2000 the company introduced Pyrazyamide in the market. Since the product is being well accepted in the market the company is planning to increase the capacity of Pyrazyamide of 180 TPA and have also finalised on other products Cislactum,which is a intermediate used to produce Diltiazem an anti anginal drug.The Company combine their intrinsic strengths in chemistry with capabilities of process development, right from laboratory scale topilot scale in pilot plant and finally manufacturing at the commercial scale in manufacturing facilities, which are in line with cGMP requirements. A combination of chemistry knowledge, with engineering strengths, along with good analytical backup enables Godavari Drugs to develop, scale, up and manufacture products right from laboratory to commercial scale.
Read More

Godavari Drugs Ltd FAQs

You can easily buy Godavari Drugs Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage